This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

SafeCode Drug Technologies Corporation Identifies The Technology Group To Commence And Develop The World's First Prototype For Its Next Generation Application For Drug Safety Administration

Stocks in this article: SAFC

JERUSALEM, December 5, 2012 /PRNewswire/ --

SafeCode Drug Technologies Corp. (OTCBB: SAFC)(the "Company"), a developer of patent-pending voice recognition technology that reduces the risks of errors during the administration of prescription medications, is pleased to announced it has identified and is commencing to develop the world's first prototype for its next generation application for Drug Safety Administration. The prototype development and the technology application is expected to be completed within 4-6 months and will be then demonstrated to worldwide major drug container manufacturers for possible adoption to ensure a new generation drug administration safety application.

The Company recently launched its new website which has also been optimized for accessibility and easy navigation on smartphones and tablets as well as laptops and home computers.  

In conjunction with the website unveiling, the Company has published a new video demonstrating the SafeCode voice-activation technology as a novel product candidate for the medical industry.  Investors are encouraged to view the video on the Company's website or on YouTube at http://www.youtube.com/watch?v=PEy9ygT6jaA.

Across the past month, the Company has been granted eligibility status by the Depository Trust Company and commenced trading on the OTC Bulletin Boards.

"We are dedicated to providing a high-quality product and transparency to our stakeholders. We are taking all necessary steps to meet these corporate goals and doing so in an expeditious manner," said Joel Klopfer, Chief Executive Officer at SafeCode Drug Technologies Corp.  "Accidental deaths resulting from administering incorrect medication represent a multi-billion-dollar area of unmet need.  We believe that we have a solution with our patent-pending voice-recognition technology that will benefit manufacturers, pharmacists and patients while building our corporate value.  This is an exciting time for our company and shareholders as we enter the commercialization phase.  The new website was important to us as it showcases the SafeCode solution while giving investors fast, user-friendly access to information on our company."

About SafeCode Drug Technologies

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,719.00 +33.27 0.19%
S&P 500 2,052.75 +4.03 0.20%
NASDAQ 4,701.8670 +26.1550 0.56%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs